0001437749-19-012300.txt : 20190619
0001437749-19-012300.hdr.sgml : 20190619
20190619171609
ACCESSION NUMBER: 0001437749-19-012300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190619
FILED AS OF DATE: 20190619
DATE AS OF CHANGE: 20190619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Remeditex Ventures LLC
CENTRAL INDEX KEY: 0001627363
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38815
FILM NUMBER: 19906744
BUSINESS ADDRESS:
STREET 1: 2101 CEDAR SPRINGS ROAD, SUITE 601
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: (214) 506-2662
MAIL ADDRESS:
STREET 1: 2101 CEDAR SPRINGS ROAD, SUITE 601
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Soliton, Inc.
CENTRAL INDEX KEY: 0001548187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 364729076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1225 NORTH LOOP WEST, STE. 725
CITY: HOUSTON
STATE: TX
ZIP: 77008
BUSINESS PHONE: 713-305-5041
MAIL ADDRESS:
STREET 1: 1225 NORTH LOOP WEST, STE. 725
CITY: HOUSTON
STATE: TX
ZIP: 77008
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-06-19
0001548187
Soliton, Inc.
SOLY
0001627363
Remeditex Ventures LLC
2727 N. HARWOOD STREET, SUITE 200
DALLAS
TX
75201
1
Common Stock
2019-06-19
4
P
0
357143
A
8938516
D
Warrant (right to buy)
16
2019-06-19
4
P
0
250000
A
2019-06-19
Common Stock
250000
250000
D
The common stock and warrant was issued as part of a unit of securities consisting of (i) one share of the Issuer's common stock, and (ii) 0.7 of a warrant to purchase one share of common stock. The offering price of the units was $14.00 per unit.
Remeditex Ventures LLC is the record and beneficial owner of the shares of common stock and the warrant to purchase common stock subject to this Form 4 and shares voting and dispositive power over such securities with Malachite Trust, the majority owner of Remeditex Ventures LLC and Lyda Hill. Ms. Hill is the Trustee of the Malachite Trust. By reason of such relationships, Ms. Hill, the Malachite Trust and Remeditex Ventures LLC may be deemed to share voting and dispositive power over the securities owned directly by Remeditex Ventures LLC. Remeditex Ventures LLC, the Malachite Trust and Lyda Hill each disclaims beneficial ownership of the reported securities except to the extent of its or her pecuniary interest therein.
The warrant expires five years after the effective date of the resale registration statement registering the shares of common stock underlying the warrant, or when such shares may sold without restriction pursuant to Rule 144 of the Securities Act of 1933.
/s/ Brett Ringle
2019-06-19